Kerry Flom

2.0k total citations · 1 hit paper
10 papers, 1.6k citations indexed

About

Kerry Flom is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Kerry Flom has authored 10 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Kerry Flom's work include Bladder and Urothelial Cancer Treatments (3 papers), HER2/EGFR in Cancer Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Kerry Flom is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), HER2/EGFR in Cancer Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Kerry Flom collaborates with scholars based in United States and Germany. Kerry Flom's co-authors include Leslie Bernstein, Dennis J. Slamon, Michael F. Press, Jianyuan Zhou, Jinha Park, Adel K. El‐Naggar, Jeffrey S. Ross, Gene Hung, S R Wolman and P. Thomas and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Clinical Chemistry.

In The Last Decade

Kerry Flom

10 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

1997 643 citations Michael F. Press, Leslie Bernstein et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kerry Flom United States	7	976	558	522	395	368	10	1.6k
Wolf‐Dietrich Beecken Germany	15	426 0.4×	194 0.3×	356 0.7×	127 0.3×	164 0.4×	24	1.1k
Alberto Pisacane Italy	21	624 0.6×	147 0.3×	486 0.9×	245 0.6×	269 0.7×	49	1.4k
Kay Friedrichs Germany	16	674 0.7×	88 0.2×	521 1.0×	121 0.3×	479 1.3×	34	1.4k
Holger Dieterich Switzerland	11	793 0.8×	158 0.3×	736 1.4×	167 0.4×	579 1.6×	14	1.6k
Serena S. Kwek United States	20	1.5k 1.6×	82 0.1×	701 1.3×	165 0.4×	236 0.6×	27	2.3k
Kim Wilber Switzerland	14	627 0.6×	166 0.3×	787 1.5×	202 0.5×	395 1.1×	16	1.5k
Alison Cheung Canada	14	684 0.7×	146 0.3×	1.3k 2.5×	97 0.2×	488 1.3×	26	1.9k
Vadim S. Koshkin United States	18	544 0.6×	143 0.3×	335 0.6×	670 1.7×	183 0.5×	118	1.3k
Huiying Piao United States	10	442 0.5×	94 0.2×	715 1.4×	125 0.3×	168 0.5×	10	1.2k
David Clouston Australia	20	279 0.3×	98 0.2×	453 0.9×	163 0.4×	202 0.5×	49	1.3k

Countries citing papers authored by Kerry Flom

Since Specialization

Citations

This map shows the geographic impact of Kerry Flom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Flom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Flom more than expected).

Fields of papers citing papers by Kerry Flom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry Flom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Flom. The network helps show where Kerry Flom may publish in the future.

Co-authorship network of co-authors of Kerry Flom

This figure shows the co-authorship network connecting the top 25 collaborators of Kerry Flom. A scholar is included among the top collaborators of Kerry Flom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerry Flom. Kerry Flom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Press, Michael F., Guido Sauter, Marc Buyse, et al.. (2010). Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy. Journal of Clinical Oncology. 29(7). 859–867. 146 indexed citations

2.

Press, MF, R. Mass, Jane Sullivan‐Halley, et al.. (2005). Association of topoisomerase II-alpha (TOP2A) gene amplification with responsiveness to anthracycline-containing chemotherapy among women with metastatic breast cancer entered in the Herceptin H0648g pivotal clinical trial. Journal of Clinical Oncology. 23(16_suppl). 9543–9543. 7 indexed citations

3.

Sarosdy, Michael F., Paul F. Schellhammer, Gary Bokinsky, et al.. (2002). Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer. The Journal of Urology. 168(5). 1950–1954. 194 indexed citations

4.

Sarosdy, Michael F., Paul F. Schellhammer, Gary Bokinsky, et al.. (2002). Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.. PubMed. 168(5). 1950–4. 214 indexed citations

5.

Sarosdy, Michael F., Paul F. Schellhammer, Gary Bokinsky, et al.. (2002). Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer. The Journal of Urology. 1950–1954. 2 indexed citations

6.

Press, Michael F., Dennis J. Slamon, Kerry Flom, et al.. (2002). Evaluation of HER-2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer Specimens. Journal of Clinical Oncology. 20(14). 3095–3105. 312 indexed citations

7.

Press, Michael F., Leslie Bernstein, P. Thomas, et al.. (1997). HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.. Journal of Clinical Oncology. 15(8). 2894–2904. 643 indexed citations breakdown →

8.

Wolman, Sandra R., et al.. (1995). Genetic probes in cytology: Principles and applications. Diagnostic Cytopathology. 13(5). 429–435. 6 indexed citations

9.

Hagerman, Randi J., Philip Wilson, Louise W. Staley, et al.. (1994). Evaluation of school children at high risk for fragile X syndrome utilizing buccal cell FMR‐1 testing. American Journal of Medical Genetics. 51(4). 474–481. 46 indexed citations

10.

Miller, W. Greg, et al.. (1991). Effect of freezing on cholesterol in individual sera. Clinical Chemistry. 37(4). 584–585. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact